Europe’s biotechnology industry is finally beginning to catch up with the US,
according to the international consultancy Ernst & Young. Ken Lee, coauthor
of Ernst & Young’s annual snapshot of the industry, says that the US, with
1287 biotech companies in April 1997, still has the lead, although this figure
represents a drop of 2 per cent on the previous year. But Europe is expanding
rapidly, boasting 716 companies compared to 584 the year before.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
Fully autonomous drones have killed human soldiers for the first time
2
Understanding anorexia’s grip on the brain could unlock new therapies
3
Toy universe shows that time could be a quantum illusion
4
Ditching cigarettes for vapes may curb the cancer benefits of quitting
5
Why we should all take quantum physics extremely personally
6
Millions of fossil whale bones found in deep-ocean ‘necropolis’
7
El Niño has started and the weather could get weird
8
What is a ‘normal’ memory slowdown, and when should I worry?
9
Unpicking endometriosis reveals how it affects more than the pelvis
10
Hundreds of new moons are revealing our solar system's violent history
